Logo image
Viscoelastic Coagulation Monitor as a Novel Device to Assess Coagulation at the Bedside. A Single-Center Experience During the COVID-19 Pandemic
Journal article   Open access   Peer reviewed

Viscoelastic Coagulation Monitor as a Novel Device to Assess Coagulation at the Bedside. A Single-Center Experience During the COVID-19 Pandemic

Mauro Panigada, Andrea Meli, Eleonora Scotti, Paolo Properzi, Matteo Brioni, Shady Kamel, Stefano Ghirardello, Luigia Scudeller, Heidi J. Dalton and Giacomo Grasselli
ASAIO Journal, Vol.67(3)
2021

Abstract

Adult Blood Coagulation COVID-19 Female Humans Male Middle Aged Monitoring, Physiologic Point-of-Care Systems Retrospective Studies SARS-CoV-2 Thrombelastography Thrombosis Coagulation Diagnosis Viscoelasticity alanine aminotransferase aspartate aminotransferase C reactive protein D dimer ferritin fibrinogen hemoglobin heparin lactate dehydrogenase low molecular weight heparin Clot formation Clotting time Formation time Low molecular weight Novel devices Portable device Thromboelastography Thrombose Viscoelastic coagulation monitor Viscoelastics activated partial thromboplastin time adult aged alanine aminotransferase blood level anticoagulant therapy Article aspartate aminotransferase blood level blood cell count blood clot lysis blood clotting time blood gas analysis blood sampling clot formation time cohort analysis continuous infusion controlled study coronavirus disease 2019 diagnostic accuracy diagnostic test accuracy study extracorporeal oxygenation female ferritin blood level fibrinogen blood level fibrinolysis hemoglobin blood level human hypercoagulability intensive care kidney failure kidney function laboratory test lactate dehydrogenase blood level leukocyte major clinical study male pandemic platelet count point of care testing prothrombin time retrospective study thromboelastography viscoelasticity blood blood clotting complication devices middle aged physiologic monitoring point of care system procedures thrombosis virology COVID-19
Viscoelastic coagulation monitor (VCM) is a portable device developed to evaluate the viscoelastic properties of whole blood activated by contact with glass. In this study, VCM was employed to analyze the viscoelastic profiles of 36 COVID-19 intensive care patients. Full anticoagulant dose heparin (unfractionated [UFH]; low molecular weight [LMWH]) was administrated to all patients. The association between VCM and laboratory parameters was retrospectively analyzed. The administration of UFH-influenced VCM parameters prolonging clotting time (CT) and clot formation time (CFT) and reducing angle (alpha) and amplitudes of the VCM tracings (A10, A20, and maximum clot firmness [MCF]) compared with LMWH therapy. A tendency toward hypercoagulation was observed by short CT and CFT in patients receiving LMWH. Clotting time was correlated with UFH dose (Spearman's rho = 0.48, p ≤ 0.001), and no correlation was found between CT and LMWH. All VCM tracings failed to show lysis at 30 and 45 minutes, indicating the absence of fibrinolysis. A10, A20, and MCF exhibited very-good to good diagnostic accuracy for detecting platelet count and fibrinogen above the upper reference limit of the laboratory. In conclusion, VCM provided reliable results in COVID-19 patients and was easy to perform with minimal training at the bedside. Copyright © ASAIO 2020.
url
https://doi.org/10.1097/MAT.0000000000001380View
Published (Version of record) Open

Metrics

3 Record Views

Details

Logo image